What sector does Indegene Limited belong to?

Indegene Limited operates in the Healthcare sector, specifically the Healthcare Research, Analytics & Technology industry, and is listed on the NSE.

What is the current share price of INDGN?

As of the latest available quote, INDGN traded at ₹578.35. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of INDGN?

Indegene Limited has a price-to-earnings (P/E) ratio of about 34.84. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of INDGN?

The market capitalisation of Indegene Limited is approximately ₹13,934 Cr.

Is Indegene Limited profitable?

For its latest reported financial year, Indegene Limited recorded a net profit margin of about 11.42%.

Does INDGN pay a dividend?

Indegene Limited does not currently show a dividend yield in our data.

What is the return on equity (ROE) of INDGN?

Indegene Limited has a return on equity (ROE) of about 14.40%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of INDGN?

Over the past 52 weeks, INDGN has traded between a low of ₹414.00 and a high of ₹615.50.

Indegene Limited

INDGN NSE Healthcare Healthcare Research, Analytics & Technology

Nifty 500 Smallcap 250

₹578.35

+0.17%

Delayed · cached 15 min

Fair value analysis

INDGN

Indegene Limited

₹577.35

Close used for this calculation

₹466.74Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

49/100

Profitability17/25

Returns7/25

Balance Sheet21/25

Efficiency4/25

Growth6/25

Average

Quality radar

Consensus fair value

₹466.74

Above FV

▼ -19.2% against the close used

Model range ₹193.14 – ₹646.85

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹193.14Fair value₹466.74Bull₹646.85

FairClose

52-week traded range

52W low ₹423.5052W high ₹611.65

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Indegene Limited closed at ₹577.35, 23.7% above the consensus fair value of ₹466.74 drawn from 9 valuation models.

Financial DNA score 49/100 — Average. P/E of 33.5x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹498.40

-13.7%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₹224.54

-61.1%

√(22.5 × EPS × BVPS)

EPS=16.65, BVPS=134.58 · outside Graham range (P/E 33.5, P/B 4.3) — asset-light, treat as a rough floor

Graham Formula

₹490.10

-15.1%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=11.6%, FD=7%

P/E Fair Value

₹646.85

+12.0%

EPS × 38.85x (sector P/E)

EPS=16.65, Sector P/E=38.85x

Peter Lynch (PEG)

₹193.14

-66.5%

EPS × Growth% (PEG = 1 is fair)

EPS=16.65, g=11.6%

EV/EBITDA

₹481.76

-16.6%

(EBITDA × 15.8x − Net Debt) ÷ Shares

EBITDA=7.45B

Book Value (P/B)

₹282.62

-51.0%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=134.58, ROE=14.4%, g=6%, r=10%

Reverse DCF

₹577.35

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 14.6% | Historical: 11.6%

Margin of Safety

₹348.73

-39.6%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=464.97, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer